Status:
UNKNOWN
Remote ECG Monitoring of TAVI Patients
Lead Sponsor:
Population Health Research Institute
Collaborating Sponsors:
Hamilton Health Sciences Corporation
Southlake Regional Health Centre
Conditions:
Cardiac Valve Disease
Aortic Valve Stenosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
After surgery, patients who undergo transcatheter aortic valve implantation (TAVI) are at risk of developing cardiac arrhythmias such as heart blocks and atrial fibrillation. Current practice is to mo...
Detailed Description
Aortic stenosis (AS), the most common valvular heart disease, occurs when there is a narrowing of the aortic valve opening. New transcatheter aortic valve implantation (TAVI, also called transcatheter...
Eligibility Criteria
Inclusion
- All patients selected for TAVI procedure that do not meet exclusion criteria and provide informed consent.
Exclusion
- Patients with prior PPM or ICD
- Patient in-hospital awaiting TAVI
- Resting 12-lead ECG shows first degree AV block, plus LAHB plus RBBB; high grade 2nd or 3rd degree heart block
Key Trial Info
Start Date :
June 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03810820
Start Date
June 20 2018
End Date
July 30 2021
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton Health Sciences Corporation - Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2